U.S. markets close in 3 hours 41 minutes

Iterum Therapeutics plc (ITRM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.7960-0.0240 (-2.93%)
As of 12:19PM EST. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
37
869
508
0
Operating Expense
75,324
102,058
77,428
29,963
13,359
Operating Income
-75,324
-102,021
-76,559
-29,455
-13,359
Net Non Operating Interest Income Expense
-7,293
-861
-426
277
0
Other Income Expense
-464
196
401
216
8
Pretax Income
-83,081
-102,686
-76,584
-28,962
-13,351
Tax Provision
452
444
472
444
113
Net Income Common Stockholders
-83,533
-103,130
-77,056
-29,406
-13,464
Diluted NI Available to Com Stockholders
-83,533
-103,130
-77,056
-29,406
-13,464
Basic EPS
-
-0.0071
-0.0071
-0.005
-0.0018
Diluted EPS
-
-0.0071
-0.0071
-0.005
-0.0018
Basic Average Shares
-
14,518
8,734
5,859
7,594
Diluted Average Shares
-
14,518
8,734
5,859
7,594
Total Operating Income as Reported
-75,324
-102,021
-76,559
-29,455
-13,359
Total Expenses
75,324
102,058
77,428
29,963
13,359
Net Income from Continuing & Discontinued Operation
-83,533
-103,130
-77,056
-29,406
-13,464
Normalized Income
-83,533
-103,130
-77,056
-29,406
-13,464
Interest Income
-
-
-
277
0
Interest Expense
7,293
861
426
-277
0
Net Interest Income
-7,293
-861
-426
277
0
EBIT
-75,788
-101,825
-76,158
-29,239
-13,351
EBITDA
-75,632
-
-
-
-
Reconciled Depreciation
156
152
136
65
0
Net Income from Continuing Operation Net Minority Interest
-83,533
-103,130
-77,056
-29,406
-13,464
Normalized EBITDA
-75,632
-101,673
-76,022
-29,174
-13,351
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0